BACKGROUND: Time trends in cancer incidence rates (IR) are important to measure the changing burden of cancer on a population over time. The overall IR of cancer in the United States is declining. Although central nervous system tumors (CNST) are rare, they contribute disproportionately to mortality and morbidity. In this analysis, the authors examined trends in the incidence of the most common cancers and CNST between 2000 and 2010. METHODS: The current analysis used data from the United States Cancer Statistics publication and the Central Brain Tumor Registry of the United States. Age-adjusted IR per 100,000 population with 95% confidence intervals and the annual percent change (APC) with 95% confidence intervals were calculated for selected common cancers and CNST overall and by age, sex, race/ethnicity, selected histologies, and malignancy status. RESULTS: In adults, there were significant decreases in colon
INTRODUCTION
Recent cancer surveillance reports have documented a significant decrease in incidence rates (IR) of adult cancer overall, as well as significant declines in the most common adult cancers (female breast, colon, lung, and prostate). 1 This is not the case in childhood cancers, in which IR have been increasing, driven largely by increases in leukemia and central nervous system tumors (CNST). 2 CNST are rare in adults, and are either malignant (age-adjusted IR of 8.85 per 100,000 population) or nonmalignant (age-adjusted IR of 18.53 per 100,000 population). 3 Malignant CNST (MCNST) contribute disproportionately to cancer mortality: they are the second leading cause of cancer mortality in men aged 20 to 39 years and the fifth leading cause in women aged 20 to 39 years. 3 They are the most common solid tumor and the second most common cancer diagnosed overall among children aged <15 years, 4 as well as the second leading cause of cancer mortality in individuals aged <20 years. 1, 2 Although overall time trends in cancer incidence are important to measure the economic and public health impact of cancer in the United States, these measures may underestimate the burden imposed by rare cancers. In the current study, we examined the incidence time trends in the most common cancers diagnosed in adults (female breast, colon, lung, and prostate) 1 
MATERIALS AND METHODS

Data Collection
The current study was conducted under approval from the University Hospitals Case Medical Center Institutional Review Board. The Central Brain Tumor Registry of the United States (CBTRUS) is to our knowledge the largest aggregation of population-based incidence data on primary CNST in the United States. 3 The CBTRUS contains incidence data from 50 central cancer registries (45 National Program of Cancer Registries and 5 Surveillance, Epidemiology, and End Results [SEER] registries), representing approximately 98% of the US population. 3 The current study used the CBTRUS analytic file to examine trends in the incidence of malignant CNST (MCNST) from 2000 to 2010 and nonmalignant CNST (NMCNST) 
RESULTS
The most common cancers diagnosed in adults between 2000 and 2010 were those of the prostate (IR, 215.96 per 100,000 population), breast (IR, 173.65 per 100,000 population), lung/bronchus (IR, 95.40 per 100,000 population), and colon and rectum (IR, 68.52 per 100,000 population), which all exceeded the IR of MCNST (IR, 8.93 per 100,000 population) (Fig. 1) . The IR of cancers of the prostate, lung, breast, and colon all decreased over the entire study period ( (Fig. 3A) .
Among the selected histologies, those with the highest incidence in adolescents between 2000 and 2010 were HL (IR, 3.18 per 100,000 population), MCNST (IR, 2.41 per 100,000 population), and NHL (IR, 1.72 per 100,000 population) (Fig. 1 ). There were significant increases noted in the IR of MCNST (Table 2) (Fig. 2B ) and NMCNST (Table 2) (Fig. 3B) , whereas the other cancers remained stable.
Among the selected histologies, those with the highest incidence in children between 2000 and 2010 were ALL (IR, 3.84 per 100,000 population), MCNST (IR, 3.57 per 100,000 population), and NHL (IR, 0.93 per 100,000 population) (Fig. 1 ). There were significant increases in the IR of ALL, NHL, and MCNST, whereas the IR of the other cancers remained stable (Table 2) (Fig.  2C ). There were no significant increases or decreases noted in NMCNST (Table 2) (Fig. 3C) . 
Incidence Trends by Sex
Incidence trends in adults varied significantly by sex (Table 1). The incidence of colon and lung/bronchus cancer decreased significantly in both men and women, although the magnitude of the decrease was found to be larger in men. The incidence of MCNST decreased significantly in men (2008-2010: APC, 23.2) but remained stable in women. The incidence of NMCNST increased significantly in both men and women (2004-2010: APC for men, 2.8; APC for women, 2.8).
Incidence trends for adolescents also varied by sex. AML decreased significantly for females but not for males 
Incidence Trends in Specific CNST Histologies
The most common MCNST histology in adults was glioblastoma (IR, 4.37 per 100,000 population) (Fig. 1 ). There were significant decreases in anaplastic astrocytoma (Fig.  3A) . Low-grade glioma was the most common MCNST noted in adolescents (IR, 0.46 per 100,000 population), and embryonal tumors were most common in children (IR, 0.78 per 100,000 population) (Fig. 1) . All MCNST histologies remained stable in adolescents (Fig. 3B) and children (Fig. 3C) (Fig. 4B ), but the IR in children were stable for the entire period (Fig. 4C) .
DISCUSSION
Incidence Trends in Adult Cancers
The 4 most common types of cancer diagnosed in the United States from 2000 through 2010 were prostate (14.8% of new cases among individuals aged 20 years from 2000-2010), lung and bronchus (14.4%), breast (14.2%), and colorectal cancer (10.3%). 6 In comparison, CNST comprised approximately 1.2% of new cancer cases within the same period. Although there were significant changes in cancer incidence noted between 2000 and 2010, there was significant heterogeneity in these trends based on tumor site, histology, and demographic factors. Many of the common cancers in adults experienced 1 This decline was driven mostly by decreases in the incidence of colorectal, prostate, and lung cancer. 4 Although these broader trends can be interpreted as a sign of success in cancer prevention programs, they can also obscure the potential burden caused by rarer cancers. Changes in incidence trends of CNST overall and by specific subtypes were present when analyzing data from 2000 through 2010, although significant trends were generally not present over the entire time period examined. At the end of the time period examined, there were significant decreases observed in the CNST incidence overall, as well as in the incidence of gliomas and malignant meningioma. There were significant increases in the incidence of NMCNST overall. Several recent analyses have attempted to determine whether there have been significant changes in the incidence of CNST. Some of these have worked to assess trends that may be associated with the popularization of cellular telephones. 9, 10 These analyses have compared IR time trends with incidence projections based on risk estimates derived from case-control studies of cellular telephone use and CNST; however, neither of these studies found a significant increase in the incidence of glioma. 11, 12 An analysis of Israeli cancer registry data demonstrated a significant decrease in low-grade glioma (WHO grade 2) and a significant increase in high-grade glioma (WHO grade 3-4) from 1980 through 2009. 13 Time trends in CNST incidence appear to be similar in the United States, Australia, and England. Other analyses of CNST trends have also found negative trends. A SEER-based analysis found small but statistically significant decreases in the incidence of all CNST in both men (APC, 20.6) and women (APC, 20.2) from 1992 through 2007. 10 Another analysis found no significant change in the incidence of glioma or astrocytoma from 1992 through 2007, but did find a small but statistically significant increase in high-grade glioma (APC, 0.64) and a significant decrease in low-grade glioma (APC, 23.02).
12 An analysis of the English cancer registry data found no significant increase in the incidence of CNST from 1998 through 2007. 12 An analysis of CNST cases collected from one state and one territory in Australia from 2000 through 2008 found a significant increase in the incidence of glioblastoma (APC, 2.5), and a significant decrease in the incidence of vestibular schwannoma (APC, 23.5).
14 Taken together, these studies do not provide consistent evidence of an increase in the incidence over time for CNST.
Incidence Trends in Childhood Cancers
US cancer incidence for individuals aged <20 years has increased slightly since 1975 (APC, 0.6). 2 Analyses of childhood cancer incidence in other countries have demonstrated similar increases in Australia and Europe. 15, 16 We found a significant increase in the incidence of ALL, NHL, and MCNST in children from 2000 through 2010, but no significant change in incidence was noted for AML, HL, or NMCNST. A recent analysis of the SEER 9 registries from 1973 to 2009 17 found a much larger increase in childhood brain tumor IR overall between 1983 and 1986 for children aged birth to 14 years, and a nonsignificant increase between 1987 and 2009. This analysis also found an increase in the incidence of gliomas across the entire period examined.
Because the incidence of CNST peaks among young children (those aged <5 years) and then again in the fifth to seventh decades of life, 3 CNST among adolescents and young adults is rarely examined. The incidence of MCNST and NMCNST increased in adolescents, but there were no significant changes in the incidence of lymphoma or leukemia noted from 2000 through 2010. The rarity of cancer in this age group may make it difficult to detect statistically significant differences over time. An analysis of data collected using the Automated Childhood Cancer Information System (ACCIS) found significant increases in CNST among adolescents aged 15 to 19 years (APC, 1.4; P<0.0001) between 1970 and 1999, but it is difficult to assess whether these increases may have been influenced by the popularization of new imaging technology during this time. 18 Incidence Trends in NMCNST Reporting of NMCNST became mandatory in 2004 with the passage of the Benign Brain Tumor Cancer Registries Amendment Act, although several state registries had collected these data both actively and passively before the mandate. 5 Due to the short period that NMCNST reporting has been mandated, it is difficult to determine whether apparent increases in these tumor types are due to improvements in case ascertainment over time. A previous CBTRUS analysis examined NMCNST cases collected from 1997 through 2008 from 11 population-based cancer registries 5 and found a significant increase in incidence 
Effect of Potential Bias on Incidence Trends
When examining cancer incidence trends, it is important to take into account other factors that can obscure incidence. The incidence of female breast and prostate cancer has previously been shown to be significantly affected by screening bias, 19, 20 and changes in the screening recommendations for these 2 cancers may be related to the decline in their IR. 21 Previous reports documented a dramatic increase in CNST incidence in the 1970s and 1980s, 22, 23 which has been attributed to improvements in diagnostic imaging techniques such as magnetic resonance imaging and computed tomography. The majority of analyses that examined diagnoses made since the early 1980s (when computed tomography became widely available) and the early 1990s (when magnetic resonance imaging became widely available) have found no significant increases in CNST incidence over time. 14, 22 Previous analyses have examined the incidence of CNST in the US population. 23 However, significant differences exist between CNST histologies, making the examination of individual tumor types important. In particular, the diagnosis of oligodendroglioma is somewhat subjective and thus varies significantly between pathologists. Hence, the incidence of oligodendroglioma and oligoastrocytoma (mixed glioma) also can vary considerably, 24, 25 as shown in the current study. The changes over time in the incidence of these 2 glioma subtypes likely Original Article reflect the increased use by pathologists of molecular markers to supplement morphological data to yield more precise and objective diagnoses among these tumor subtypes (eg, chromosomal loss at 1p and/or 19q). [26] [27] [28] CBTRUS represents approximately 98% of all brain tumor diagnoses in the United States and distinguishes between CNST histologies. The current study analyzed incident cancer cases from 2000 through 2010, a time period during which diagnostic imaging technology was widely established and universally available for all cancers and during which time pathological diagnosis became increasingly supplemented by molecular information in an attempt to improve the precision and objectivity of the histopathological diagnosis of specific subtypes of CNST and other cancers.
Conclusions
The incidence of the most common cancers in adults decreased between 2000 and 2010, as did the incidence of MCNST. However, the incidence of NMCNST increased significantly. In comparison, adolescents had increasing rates of MCNST and NMCNST, and children had increasing rates of AML, NHL, and MCNST. Cancer in adolescents, especially CNST, is an understudied topic and deserves further individual examination to characterize the burden of CNST on adolescents and young adults in the United States. Surveillance of cancer incidence trends is an important measure of the changing public health and economic burden of cancer in the United States, as well as a tool with which to assess the success of cancer prevention programs. It is important to assess rare cancer types separately and compare their incidence with that of other common cancers.
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